Neuronetics Reports Updated Q4 Results; Net Loss $(0.33)

Fourth Quarter 2024 Results for the Three Months Ended December 31, 2024

• a $0.6 million reduction in the 2024 bonus accrual that the Company assumed in connection with its acquisition of Greenbrook, resulting in an increase in the Company's operating expenses from $25.8 million, as reported in the Initial Release, to $26.4 million under applicable purchasing accounting principles;
• an increase in the net loss and net loss per share from $(12.2) million and $(0.33), respectively, as reported in the Initial Release, to $(12.7) million and $(0.34), respectively; and
• a decrease in the adjusted EBITDA from $0.1 million, as reported in the Initial Release, to $(0.4) million.